Your strategic partner in evidence & access
Senior, independent health economics and outcomes research (HEOR), real-world evidence (RWE) and health technology assessment (HTA) / market-access advisory for Southeast Asia (SEA) and Asia-Pacific (APAC) — helping sponsors and their delivery partners build, and payers judge, evidence that proves genuine value.
Four ways a single senior partner changes the outcome of your evidence and access work.
The right evidence questions and study choices identified early and aligned to payer and market needs — saving time, budget and rework.
Access to vetted, fit-for-purpose CROs and consultancies, and help selecting and managing them — without costly trial and error.
Senior oversight that catches issues early, flags risks and assures quality and timelines on your evidence projects.
Value arguments and evidence that stand up to HTA and payer scrutiny across APAC and SEA.
Founder & Principal Consultant

For 18+ years I have worked at the intersection of evidence and access — generating HEOR and RWE inside leading global pharmaceutical companies, and leading its delivery as a Managing Principal at a global contract research organization (CRO) and specialized consultancy, where I built and scaled an RWE and HEOR practice across Asia-Pacific (APAC) and Southeast Asia (SEA) — growing it to a 25+ consultant team across 500+ projects.
I founded SP Health Analytics to bring that senior, independent perspective directly to the organizations that need it. I sit at the intersection of the sponsors who need evidence, the CROs and consultancies who generate it, and the payers and HTA bodies who judge it — making sure the right evidence is built, by the right partner, with the right solution, to answer the right question. What I bring is “both sides of the table” experience, regional SEA / APAC fluency in HTA, pricing and reimbursement, policy-level reach, and a single senior expert who is accountable — not a layered team.
The right evidence, by the right partner, to answer the right question.
Sponsor, CRO and payer experience — we understand the need and speak every language.
A single senior partner, not a layered team, with no incentive to oversell scope.
Neutral by default and aligned to your goals, with clear disclosure.
Everything is built to stand up to HTA and payer scrutiny across SEA and APAC.
Engagements scale to the need — from a focused advisory input or expert review, to leading the evidence strategy for a launch, to setting up a partner’s capability, to ongoing oversight of a multi-country evidence program. Pillars can be combined. Click any pillar to see what it covers.
Hands-on depth across the methods that HTA bodies and payers expect — matched to the right question, not a one-size-fits-all study.
CEA — cost-effectiveness analysis · CUA — cost-utility analysis · BIA — budget-impact analysis · PRO — patient-reported outcome · EMR / EHR — electronic medical / health record.
If you are navigating market access, evidence generation or HTA in SEA / APAC, or building an RWE / HEOR capability, I would be glad to connect.
Email
sp@sphealthanalytics.com
Phone
+66 (0)65 914 1416
LinkedIn
linkedin.com/company/sp-health-analytics
Based in
Bangkok, Thailand · Serving Southeast Asia & APAC